MedTrace Logo

Rapid HIV Tests for Women Late in Pregnancy and During Labor

NCT00046436 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 7500

Last updated 2013-06-03

No results posted yet for this study

Summary

This study will look at how well the OraQuick HIV 1/2 Antibody rapid test works and how women accept being tested for HIV late in pregnancy and during labor. For women with positive test results, the study will look at whether or not these women accept anti-HIV drugs and which drugs they receive.

Conditions

  • HIV Infections

Sponsors & Collaborators

  • Centers for Disease Control and Prevention

    collaborator FED

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

    collaborator NIH

  • National Institute of Allergy and Infectious Diseases (NIAID)

    lead NIH

Principal Investigators

  • Robert Maupin, Jr., MD · Louisiana State University Health Sciences Center in New Orleans

Eligibility

Min Age
13 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Completion
2004-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00046436 on ClinicalTrials.gov